Cleared Traditional

K213978 - TELIGEN System

K213978 is an FDA 510(k) clearance for TELIGEN System, manufactured by Medos International SARL. The device is a Class 2 Orthopedic device with product code HRX cleared through the Traditional 510(k) pathway after a 302-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
302d
Days
Class 2
Risk

K213978 is an FDA 510(k) clearance for the TELIGEN System. Classified as Arthroscope (product code HRX), Class II - Special Controls.

Submitted by Medos International SARL (Lelocle, CH). The FDA issued a Cleared decision on October 18, 2022 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.1100 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medos International SARL devices

FDA 510(k) Submission Details - K213978

510(k) Number K213978 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date October 18, 2022
Days to Decision 302 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
180d slower than avg
Panel avg: 122d · This submission: 302d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HRX Device Classification - Class 2, Special Controls

Product Code HRX Arthroscope
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.1100
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - HRX Arthroscope

All 521
Devices cleared under the same product code (HRX) and FDA review panel - the closest regulatory comparables to K213978.
SmartRelease Endoscopic Soft Tissue Release System
K223406 · Microaire Surgical Instruments · Feb 2023
Pristine Arthroscopic Visualization System
K223244 · Pristine Surgical · Dec 2022
HBL Blade Assembly
K222490 · Hand Biomechanics Lab, Inc. · Nov 2022
CORUS Spinal System-X
K212636 · Providence Medical Technology, Inc. · Oct 2021
mi-eye 3 needlescope with cannula, mi-tablet 3
K212556 · Trice Medical, Inc. · Sep 2021
SMARTRELEASE Endoscopic Soft Tissue Release System
K211297 · Microaire Surgical Instruments · Jun 2021